Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

FDA announces shift to simplify COVID-19 vaccines

The recommendation updates the FDA’s emergency use authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines.

Phillips partners with Amazon to host EI offering, advance AI tools

According to Philips, the partnership with Amazon Web Services broadens its capabilities in enterprise informatics and many other key areas.

Merck to acquire Prometheus Biosciences for $10.8B

The acquisition is one of 2023's biggest healthcare deals so far.

Thumbnail

Moderna, Merck say new combination treatment boosts skin cancer survival

The new findings come after Moderna accused other pharmaceutical companies of stealing its mRNA technology for COVID-19 vaccines.

Supreme Court halts restrictions on abortion pill

The Supreme Court has stepped in to block a Texas-based federal judge’s order that pulled back the approval of mifepristone.

Thumbnail

DOJ to appeal abortion pill case to Supreme Court

“The Justice Department strongly disagrees with the Fifth Circuit’s decision in Alliance for Hippocratic Medicine v. FDA to deny in part our request for a stay pending appeal,” Attorney General Merrick Garland said April 13.

Thumbnail

Political climate leads to loss of labor and delivery services

Bonner General Health, based in Sandpoint, Idaho, alerted the public about the upcoming discontinuation of labor and delivery services.

artificial intelligence robot evaluates healthcare data

ChatGPT answers straightforward cardiology questions, but struggles with complex cases

The popular chat-based AI model was able to answer straightforward questions with considerable accuracy. However, it still has certain issues that need to be addressed. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup